Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016
Background and aimHepatitis E virus (HEV) is a virus of emerging importance to transfusion medicine. Studies from several European countries, including Switzerland, have reported high seroprevalence of hepatitis E as a consequence of endemic infections. Published HEV seroprevalence estimates within...
Uloženo v:
| Vydáno v: | Euro surveillance : bulletin européen sur les maladies transmissibles Ročník 23; číslo 35 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Sweden
Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)
30.08.2018
European Centre for Disease Prevention and Control (ECDC) |
| Témata: | |
| ISSN: | 1560-7917, 1025-496X, 1560-7917 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background and aimHepatitis E virus (HEV) is a virus of emerging importance to transfusion medicine. Studies from several European countries, including Switzerland, have reported high seroprevalence of hepatitis E as a consequence of endemic infections. Published HEV seroprevalence estimates within developed countries vary considerably; primarily due to improved diagnostic assays. The purpose of this study was to investigate the seroprevalence of anti-HEV IgG in Swiss blood donations.
We used the highly sensitive Wantai HEV IgG EIA and assessed regional distribution patterns. We analysed age- and sex-matched archive plasma dating back 20 years from canton Bern to investigate recent changes in HEV seroprevalence levels.
On average, 20.4% (95% confidence intervals: 19.1-21.8) of the 3,609 blood samples collected in 2014-16 were anti-HEV IgG positive; however, distinct differences between geographical regions were observed (range: 12.8-33.6%). Seroprevalence increased with age with 30.7% of males and 34.3% of women being positive donors over > 60 years old. Differences between sexes may be attributed to dissimilarities in the average age of this group. Within the specified region of the Bern canton, overall prevalence has declined over two decades from 30.3% in 1997/98 to 27.0% in 2006 and 22.3% in 2015/6.
HEV seroprevalence in Switzerland is high, but has declined over the last decades. The result shows that primarily endemic HEV infections occur and that current blood products may pose a risk to vulnerable transfusion recipients. Nucleic acid screening of all blood products for HEV will begin in November 2018. |
|---|---|
| AbstractList | Background and aimHepatitis E virus (HEV) is a virus of emerging importance to transfusion medicine. Studies from several European countries, including Switzerland, have reported high seroprevalence of hepatitis E as a consequence of endemic infections. Published HEV seroprevalence estimates within developed countries vary considerably; primarily due to improved diagnostic assays. The purpose of this study was to investigate the seroprevalence of anti-HEV IgG in Swiss blood donations. Methods: We used the highly sensitive Wantai HEV IgG EIA and assessed regional distribution patterns. We analysed age- and sex-matched archive plasma dating back 20 years from canton Bern to investigate recent changes in HEV seroprevalence levels. Results: On average, 20.4% (95% confidence intervals: 19.1-21.8) of the 3,609 blood samples collected in 2014-16 were anti-HEV IgG positive; however, distinct differences between geographical regions were observed (range: 12.8-33.6%). Seroprevalence increased with age with 30.7% of males and 34.3% of women being positive donors over > 60 years old. Differences between sexes may be attributed to dissimilarities in the average age of this group. Within the specified region of the Bern canton, overall prevalence has declined over two decades from 30.3% in 1997/98 to 27.0% in 2006 and 22.3% in 2015/6. Conclusions: HEV seroprevalence in Switzerland is high, but has declined over the last decades. The result shows that primarily endemic HEV infections occur and that current blood products may pose a risk to vulnerable transfusion recipients. Nucleic acid screening of all blood products for HEV will begin in November 2018.Background and aimHepatitis E virus (HEV) is a virus of emerging importance to transfusion medicine. Studies from several European countries, including Switzerland, have reported high seroprevalence of hepatitis E as a consequence of endemic infections. Published HEV seroprevalence estimates within developed countries vary considerably; primarily due to improved diagnostic assays. The purpose of this study was to investigate the seroprevalence of anti-HEV IgG in Swiss blood donations. Methods: We used the highly sensitive Wantai HEV IgG EIA and assessed regional distribution patterns. We analysed age- and sex-matched archive plasma dating back 20 years from canton Bern to investigate recent changes in HEV seroprevalence levels. Results: On average, 20.4% (95% confidence intervals: 19.1-21.8) of the 3,609 blood samples collected in 2014-16 were anti-HEV IgG positive; however, distinct differences between geographical regions were observed (range: 12.8-33.6%). Seroprevalence increased with age with 30.7% of males and 34.3% of women being positive donors over > 60 years old. Differences between sexes may be attributed to dissimilarities in the average age of this group. Within the specified region of the Bern canton, overall prevalence has declined over two decades from 30.3% in 1997/98 to 27.0% in 2006 and 22.3% in 2015/6. Conclusions: HEV seroprevalence in Switzerland is high, but has declined over the last decades. The result shows that primarily endemic HEV infections occur and that current blood products may pose a risk to vulnerable transfusion recipients. Nucleic acid screening of all blood products for HEV will begin in November 2018. Hepatitis E virus (HEV) is a virus of emerging importance to transfusion medicine. Studies from several European countries, including Switzerland, have reported high seroprevalence of hepatitis E as a consequence of endemic infections. Published HEV seroprevalence estimates within developed countries vary considerably; primarily due to improved diagnostic assays. The purpose of this study was to investigate the seroprevalence of anti-HEV IgG in Swiss blood donations. Methods: We used the highly sensitive Wantai HEV IgG EIA and assessed regional distribution patterns. We analysed age- and sex-matched archive plasma dating back 20 years from canton Bern to investigate recent changes in HEV seroprevalence levels. Results: On average, 20.4% (95% confidence intervals: 19.1–21.8) of the 3,609 blood samples collected in 2014–16 were anti-HEV IgG positive; however, distinct differences between geographical regions were observed (range: 12.8–33.6%). Seroprevalence increased with age with 30.7% of males and 34.3% of women being positive donors over > 60 years old. Differences between sexes may be attributed to dissimilarities in the average age of this group. Within the specified region of the Bern canton, overall prevalence has declined over two decades from 30.3% in 1997/98 to 27.0% in 2006 and 22.3% in 2015/6. Conclusions: HEV seroprevalence in Switzerland is high, but has declined over the last decades. The result shows that primarily endemic HEV infections occur and that current blood products may pose a risk to vulnerable transfusion recipients. Nucleic acid screening of all blood products for HEV will begin in November 2018. Background and aim Hepatitis E virus (HEV) is a virus of emerging importance to transfusion medicine. Studies from several European countries, including Switzerland, have reported high seroprevalence of hepatitis E as a consequence of endemic infections. Published HEV seroprevalence estimates within developed countries vary considerably; primarily due to improved diagnostic assays. The purpose of this study was to investigate the seroprevalence of anti-HEV IgG in Swiss blood donations. Methods: We used the highly sensitive Wantai HEV IgG EIA and assessed regional distribution patterns. We analysed age- and sex-matched archive plasma dating back 20 years from canton Bern to investigate recent changes in HEV seroprevalence levels. Results: On average, 20.4% (95% confidence intervals: 19.1–21.8) of the 3,609 blood samples collected in 2014–16 were anti-HEV IgG positive; however, distinct differences between geographical regions were observed (range: 12.8–33.6%). Seroprevalence increased with age with 30.7% of males and 34.3% of women being positive donors over > 60 years old. Differences between sexes may be attributed to dissimilarities in the average age of this group. Within the specified region of the Bern canton, overall prevalence has declined over two decades from 30.3% in 1997/98 to 27.0% in 2006 and 22.3% in 2015/6. Conclusions: HEV seroprevalence in Switzerland is high, but has declined over the last decades. The result shows that primarily endemic HEV infections occur and that current blood products may pose a risk to vulnerable transfusion recipients. Nucleic acid screening of all blood products for HEV will begin in November 2018. Background and aimHepatitis E virus (HEV) is a virus of emerging importance to transfusion medicine. Studies from several European countries, including Switzerland, have reported high seroprevalence of hepatitis E as a consequence of endemic infections. Published HEV seroprevalence estimates within developed countries vary considerably; primarily due to improved diagnostic assays. The purpose of this study was to investigate the seroprevalence of anti-HEV IgG in Swiss blood donations. We used the highly sensitive Wantai HEV IgG EIA and assessed regional distribution patterns. We analysed age- and sex-matched archive plasma dating back 20 years from canton Bern to investigate recent changes in HEV seroprevalence levels. On average, 20.4% (95% confidence intervals: 19.1-21.8) of the 3,609 blood samples collected in 2014-16 were anti-HEV IgG positive; however, distinct differences between geographical regions were observed (range: 12.8-33.6%). Seroprevalence increased with age with 30.7% of males and 34.3% of women being positive donors over > 60 years old. Differences between sexes may be attributed to dissimilarities in the average age of this group. Within the specified region of the Bern canton, overall prevalence has declined over two decades from 30.3% in 1997/98 to 27.0% in 2006 and 22.3% in 2015/6. HEV seroprevalence in Switzerland is high, but has declined over the last decades. The result shows that primarily endemic HEV infections occur and that current blood products may pose a risk to vulnerable transfusion recipients. Nucleic acid screening of all blood products for HEV will begin in November 2018. |
| Author | Sigle, Jörg Wiengand, Tina Widmer, Nadja Tinguely, Caroline Hotz, Magdalena Infanti, Laura Gowland, Peter Thierbach, Jutta Stalder, Michèle Allemann, Gabrielle Sarraj, Amira Niederhauser, Christoph Borri, Mauro Waldvogel, Sophie Fontana, Stefano Züger, Max |
| Author_xml | – sequence: 1 givenname: Christoph surname: Niederhauser fullname: Niederhauser, Christoph organization: Interregional Blood Transfusion SRC, Berne Switzerland – sequence: 2 givenname: Nadja surname: Widmer fullname: Widmer, Nadja organization: Interregional Blood Transfusion SRC, Berne Switzerland – sequence: 3 givenname: Magdalena surname: Hotz fullname: Hotz, Magdalena organization: Interregional Blood Transfusion SRC, Berne Switzerland – sequence: 4 givenname: Caroline surname: Tinguely fullname: Tinguely, Caroline organization: Interregional Blood Transfusion SRC, Berne Switzerland – sequence: 5 givenname: Stefano surname: Fontana fullname: Fontana, Stefano organization: Servizio Trasfusionale CRS della Svizzera Italiana, Lugano, Switzerland, Interregional Blood Transfusion SRC, Berne Switzerland – sequence: 6 givenname: Gabrielle surname: Allemann fullname: Allemann, Gabrielle organization: Blood Transfusion Service SRC, Fribourg, Switzerland – sequence: 7 givenname: Mauro surname: Borri fullname: Borri, Mauro organization: Servizio Trasfusionale CRS della Svizzera Italiana, Lugano, Switzerland – sequence: 8 givenname: Laura surname: Infanti fullname: Infanti, Laura organization: Blood Transfusion Service Beider Basel, Basel, Switzerland – sequence: 9 givenname: Amira surname: Sarraj fullname: Sarraj, Amira organization: Blood Transfusion Service SRC Neuchâtel/Jura, Neuchâtel, Switzerland – sequence: 10 givenname: Jörg surname: Sigle fullname: Sigle, Jörg organization: Blood Transfusion Service SRC, Aargau/Solothurn, Switzerland – sequence: 11 givenname: Michèle surname: Stalder fullname: Stalder, Michèle organization: Interregional Blood Transfusion SRC, Berne Switzerland – sequence: 12 givenname: Jutta surname: Thierbach fullname: Thierbach, Jutta organization: Blood Transfusion Service SRC Nordostschweiz, St. Gallen, Switzerland – sequence: 13 givenname: Sophie surname: Waldvogel fullname: Waldvogel, Sophie organization: Blood Transfusion Service SRC, Geneva, Switzerland – sequence: 14 givenname: Tina surname: Wiengand fullname: Wiengand, Tina organization: Blood Transfusion Service SRC Zentralschweiz, Luzern, Switzerland – sequence: 15 givenname: Max surname: Züger fullname: Züger, Max organization: Blood Transfusion Service SRC Thurgau, Münsterlingen, Switzerland – sequence: 16 givenname: Peter surname: Gowland fullname: Gowland, Peter organization: Interregional Blood Transfusion SRC, Berne Switzerland |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30180927$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkUtv1DAURi1URB_wF5AlFrCZ4EfixwZUjcJDqsRiYG05zg11lbGDnQzi3-PQYVS6YuUr-dxP39W5RGchBkDoNSUVU0S-pY0gG6mprNpdxQhVFeMVbyoqCRFUPEEXJ-LswXyOLnO-I6TmRLNn6JyXzTLJCwTbJSUIM76Fyc5-9hm3-ODTknGGFKcEBztCcIB9wLufPmfcjTH2uI8hpoxt6LGdJvsnowc3-gB4SHGPqdYSzxGXluI5ejrYMcOL43uFvn1ov24_bW6-fPy8vb7ZuFroeeNU02kilaQNQC1dI6zuYeDAhOJa9X3t3ACOwyC7gVjCal43UnaSaWpJYa7Qu_vcaen20LtSKtnRTMnvbfplovXm35_gb833eDCCspqqNeDNMSDFHwvk2ex9djCONkBcsmFEa6WUqEVBXz1C7-KSQjnPMEpJ3WimeKFePmx0qvLXQAHe3wMuxZwTDCeEErM6N6tFs1o07c6szg3jhjfm6LwktI8SnJ-Ly7ie6Mf_zvkNSy-0mA |
| CitedBy_id | crossref_primary_10_1002_hsr2_624 crossref_primary_10_21307_pjm_2018_062 crossref_primary_10_1016_j_coviro_2018_11_006 crossref_primary_10_1093_ofid_ofad595 crossref_primary_10_1111_ajt_15725 crossref_primary_10_1212_NXI_0000000000000594 crossref_primary_10_1371_journal_pone_0305521 crossref_primary_10_1155_2021_9341974 crossref_primary_10_1186_s12879_019_4190_1 crossref_primary_10_3390_pathogens13100911 crossref_primary_10_4291_wjgp_v13_i2_50 crossref_primary_10_1111_ene_16030 crossref_primary_10_1002_jmv_25498 crossref_primary_10_1017_S0950268820001429 crossref_primary_10_3390_v15010037 crossref_primary_10_3390_pathogens12030484 crossref_primary_10_3390_v11030251 crossref_primary_10_1080_20008686_2024_2406834 crossref_primary_10_1111_vox_12966 crossref_primary_10_3390_microorganisms11102375 crossref_primary_10_3390_pathogens12030425 crossref_primary_10_2147_JMDH_S328029 crossref_primary_10_1159_000499121 crossref_primary_10_1097_MEG_0000000000001853 crossref_primary_10_3390_ani11113177 crossref_primary_10_1136_jim_2021_002102 crossref_primary_10_3390_ani11113050 crossref_primary_10_1002_jmv_70483 crossref_primary_10_1097_QCO_0000000000000590 crossref_primary_10_3390_v13030492 crossref_primary_10_3748_wjg_v28_i1_47 crossref_primary_10_1186_s12985_021_01607_y crossref_primary_10_1136_archdischild_2022_324629 crossref_primary_10_3390_pathogens10020107 crossref_primary_10_1016_j_jcv_2019_09_004 |
| Cites_doi | 10.2807/1560-7917.ES2013.18.31.20550 10.1111/vox.12056 10.3201/eid1810.111756 10.1371/journal.pone.0062980 10.1016/S0140-6736(11)61849-7 10.1111/j.1423-0410.2011.01527.x 10.3201/eid1304.061387 10.1002/hep.28436 10.1093/infdis/jis688 10.3390/v8080211 10.1016/S0140-6736(80)90205-6 10.2807/1560-7917.ES2014.19.21.20812 10.1016/S0140-6736(14)61034-5 10.1128/genomeA.00888-17 10.1111/hepr.12028 10.1111/tme.12405 10.1111/trf.13028 10.1016/j.tracli.2015.06.289 10.2807/1560-7917.ES.2017.22.16.30514 10.1002/jmv.21656 10.1007/s12560-012-9087-8 10.1056/NEJMoa0706992 10.2217/fmb.14.89 10.1002/(SICI)1096-9071(199903)57:3<243::AID-JMV6>3.0.CO;2-R 10.1016/j.jcv.2009.01.005 10.1097/01.qco.0000433308.83029.97 10.3201/eid1812.120924 10.1111/trf.13402 10.1111/trf.13355 10.1055/s-0033-1338113 10.3201/eid1712.110371 10.3201/eid0904.020351 10.1016/j.virusres.2011.02.007 10.1002/hep.27244 10.1016/j.healun.2012.11.027 10.1111/j.1440-1746.2004.03437.x 10.1371/journal.pone.0021150 10.1111/trf.14089 10.1111/trf.12733 |
| ContentType | Journal Article |
| Copyright | Copyright Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS) Aug 30, 2018 This article is copyright of The Authors, 2018. 2018 The Authors |
| Copyright_xml | – notice: Copyright Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS) Aug 30, 2018 – notice: This article is copyright of The Authors, 2018. 2018 The Authors |
| DBID | AAYXX CITATION NPM 7X8 5PM |
| DOI | 10.2807/1560-7917.ES.2018.23.35.1700616 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 1560-7917 |
| ExternalDocumentID | PMC6124188 30180927 10_2807_1560_7917_ES_2018_23_35_1700616 |
| Genre | Journal Article |
| GeographicLocations | Switzerland |
| GeographicLocations_xml | – name: Switzerland |
| GroupedDBID | --- 2WC 53G 5GY 5VS 9K5 AAYXX ABOCM ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK E3Z EBD EBS EJD EMOBN F5P FRP GROUPED_DOAJ GX1 HYE IPNFZ KQ8 M48 OK1 OVT P6G PQQKQ RIG RNS RPM SV3 TR2 XSB FZ- NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c469t-c85b9078715ee47c56a9def3e268398dd4ccfec3ef7bf0a02434577b7291a0683 |
| ISICitedReferencesCount | 30 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000443855600003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1560-7917 1025-496X |
| IngestDate | Tue Sep 30 17:19:29 EDT 2025 Wed Oct 01 14:22:52 EDT 2025 Mon Jun 30 06:39:20 EDT 2025 Thu Apr 03 07:04:31 EDT 2025 Sat Nov 29 03:13:40 EST 2025 Tue Nov 18 22:15:47 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 35 |
| Keywords | hepatitis E blood donors virus seroprevalence Switzerland |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c469t-c85b9078715ee47c56a9def3e268398dd4ccfec3ef7bf0a02434577b7291a0683 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Correspondence: Christoph Niederhauser (christoph.niederhauser@itransfusion.ch) |
| OpenAccessLink | http://dx.doi.org/10.2807/1560-7917.ES.2018.23.35.1700616 |
| PMID | 30180927 |
| PQID | 2110459283 |
| PQPubID | 105456 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6124188 proquest_miscellaneous_2099888646 proquest_journals_2110459283 pubmed_primary_30180927 crossref_primary_10_2807_1560_7917_ES_2018_23_35_1700616 crossref_citationtrail_10_2807_1560_7917_ES_2018_23_35_1700616 |
| PublicationCentury | 2000 |
| PublicationDate | 2018-08-30 |
| PublicationDateYYYYMMDD | 2018-08-30 |
| PublicationDate_xml | – month: 08 year: 2018 text: 2018-08-30 day: 30 |
| PublicationDecade | 2010 |
| PublicationPlace | Sweden |
| PublicationPlace_xml | – name: Sweden – name: Saint-Maurice |
| PublicationTitle | Euro surveillance : bulletin européen sur les maladies transmissibles |
| PublicationTitleAlternate | Euro Surveill |
| PublicationYear | 2018 |
| Publisher | Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS) European Centre for Disease Prevention and Control (ECDC) |
| Publisher_xml | – name: Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS) – name: European Centre for Disease Prevention and Control (ECDC) |
| References | Crossan (r7) 2012; 18 Cleland (r29) 2013; 105 Kamar (r5) 2012; 379 Huzly (r38) 2014; 19 Dalton (r10) 2013; 26 Kaufmann (r25) 2011; 6 Wenzel (r35) 2014; 60 Mansuy (r27) 2011; 17 Hogema (r34) 2014; 54 r39 Slot (r28) 2013; 18 Khuroo (r14) 2004; 19 Hartl (r23) 2016; 8 Schlauder (r3) 1999; 57 Kokkinos (r8) 2012; 4 Colson (r15) 2007; 13 Salam (r11) 2013; 43 Schnegg (r24) 2013; 8 Kamar (r12) 2008; 358 Kubacki (r31) 2017; 5 Clemente-Casares (r4) 2003; 9 Hewitt (r16) 2014; 384 Hogema (r17) 2016; 56 Wenzel (r22) 2013; 207 Fearon (r30) 2017; 57 Ankcorn (r19) 2017; 27 Bendall (r21) 2010; 82 Riezebos-Brilman (r13) 2013; 32 Khuroo (r1) 1980; 2 Ijaz (r33) 2009; 44 Domanović (r40) 2017; 22 Baylis (r37) 2012; 102 Mansuy (r20) 2016; 63 r26 Holm (r32) 2015; 55 Stramer (r18) 2016; 56 Faber (r36) 2012; 18 Dalton (r9) 2014; 9 Khuroo (r2) 2011; 161 Meng (r6) 2013; 33 |
| References_xml | – volume: 18 start-page: 20550 issue: 31 year: 2013 ident: r28 article-title: Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. publication-title: Euro Surveill doi: 10.2807/1560-7917.ES2013.18.31.20550 – volume: 105 start-page: 283 issue: 4 year: 2013 ident: r29 article-title: Hepatitis E virus in Scottish blood donors. publication-title: Vox Sang doi: 10.1111/vox.12056 – volume: 18 start-page: 1654 issue: 10 year: 2012 ident: r36 article-title: Hepatitis E virus seroprevalence among adults, Germany. publication-title: Emerg Infect Dis doi: 10.3201/eid1810.111756 – volume: 8 start-page: e62980 issue: 5 year: 2013 ident: r24 article-title: An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population. publication-title: PLoS One doi: 10.1371/journal.pone.0062980 – volume: 379 start-page: 2477 issue: 9835 year: 2012 ident: r5 article-title: Hepatitis E. publication-title: Lancet doi: 10.1016/S0140-6736(11)61849-7 – volume: 102 start-page: 182 issue: 2 year: 2012 ident: r37 article-title: Widespread distribution of hepatitis E virus in plasma fractionation pools. publication-title: Vox Sang doi: 10.1111/j.1423-0410.2011.01527.x – volume: 13 start-page: 648 issue: 4 year: 2007 ident: r15 article-title: Transfusion-associated hepatitis E, France. publication-title: Emerg Infect Dis doi: 10.3201/eid1304.061387 – volume: 63 start-page: 1145 issue: 4 year: 2016 ident: r20 article-title: A nationwide survey of hepatitis E viral infection in French blood donors. publication-title: Hepatology doi: 10.1002/hep.28436 – volume: 207 start-page: 497 issue: 3 year: 2013 ident: r22 article-title: Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. publication-title: J Infect Dis doi: 10.1093/infdis/jis688 – volume: 8 start-page: 211 issue: 8 year: 2016 ident: r23 article-title: Hepatitis E Seroprevalence in Europe: A Meta-Analysis. publication-title: Viruses doi: 10.3390/v8080211 – volume: 2 start-page: 860 issue: 8199 year: 1980 ident: r1 article-title: Chronic liver disease after non-A, non-B hepatitis. publication-title: Lancet doi: 10.1016/S0140-6736(80)90205-6 – ident: r26 – volume: 19 start-page: 20812 issue: 21 year: 2014 ident: r38 article-title: Transfusion-transmitted hepatitis E in Germany, 2013. publication-title: Euro Surveill doi: 10.2807/1560-7917.ES2014.19.21.20812 – volume: 384 start-page: 1766 issue: 9956 year: 2014 ident: r16 article-title: Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. publication-title: Lancet doi: 10.1016/S0140-6736(14)61034-5 – volume: 5 start-page: e00888 issue: 35 year: 2017 ident: r31 article-title: Complete Genome Sequences of Two Swiss Hepatitis E Virus Isolates from Human Stool and Raw Pork Sausage. publication-title: Genome Announc doi: 10.1128/genomeA.00888-17 – volume: 43 start-page: 826 issue: 8 year: 2013 ident: r11 article-title: Serum tumor necrosis factor-alpha level in hepatitis E virus-related acute viral hepatitis and fulminant hepatic failure in pregnant women. publication-title: Hepatol Res doi: 10.1111/hepr.12028 – volume: 27 start-page: 84 issue: 2 year: 2017 ident: r19 article-title: Hepatitis E: the current state of play. publication-title: Transfus Med doi: 10.1111/tme.12405 – volume: 55 start-page: 1662 issue: 7 year: 2015 ident: r32 article-title: Declining prevalence of hepatitis E antibodies among Danish blood donors. publication-title: Transfusion doi: 10.1111/trf.13028 – ident: r39 doi: 10.1016/j.tracli.2015.06.289 – volume: 22 start-page: 30514 issue: 16 year: 2017 ident: r40 article-title: Hepatitis E and blood donation safety in selected European countries: a shift to screening? publication-title: Euro Surveill doi: 10.2807/1560-7917.ES.2017.22.16.30514 – volume: 82 start-page: 799 issue: 5 year: 2010 ident: r21 article-title: A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. publication-title: J Med Virol doi: 10.1002/jmv.21656 – volume: 4 start-page: 179 issue: 4 year: 2012 ident: r8 article-title: Harmonised investigation of the occurrence of human enteric viruses in the leafy green vegetable supply chain in three European countries. publication-title: Food Environ Virol doi: 10.1007/s12560-012-9087-8 – volume: 358 start-page: 811 issue: 8 year: 2008 ident: r12 article-title: Hepatitis E virus and chronic hepatitis in organ-transplant recipients. publication-title: N Engl J Med doi: 10.1056/NEJMoa0706992 – volume: 9 start-page: 1361 issue: 12 year: 2014 ident: r9 article-title: Hepatitis E in developed countries: current status and future perspectives. publication-title: Future Microbiol doi: 10.2217/fmb.14.89 – volume: 57 start-page: 243 issue: 3 year: 1999 ident: r3 article-title: Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV. publication-title: J Med Virol doi: 10.1002/(SICI)1096-9071(199903)57:3<243::AID-JMV6>3.0.CO;2-R – volume: 44 start-page: 272 issue: 4 year: 2009 ident: r33 article-title: Indigenous hepatitis E virus infection in England: more common than it seems. publication-title: J Clin Virol doi: 10.1016/j.jcv.2009.01.005 – volume: 26 start-page: 471 issue: 5 year: 2013 ident: r10 article-title: Hepatitis E. publication-title: Curr Opin Infect Dis doi: 10.1097/01.qco.0000433308.83029.97 – volume: 18 start-page: 2085 issue: 12 year: 2012 ident: r7 article-title: Hepatitis E virus genotype 3 in shellfish, United Kingdom. publication-title: Emerg Infect Dis doi: 10.3201/eid1812.120924 – volume: 56 start-page: 722 issue: 3 year: 2016 ident: r17 article-title: Incidence and duration of hepatitis E virus infection in Dutch blood donors. publication-title: Transfusion doi: 10.1111/trf.13402 – volume: 56 start-page: 481 issue: 2 year: 2016 ident: r18 article-title: Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors. publication-title: Transfusion doi: 10.1111/trf.13355 – volume: 33 start-page: 41 issue: 1 year: 2013 ident: r6 article-title: Zoonotic and foodborne transmission of hepatitis E virus. publication-title: Semin Liver Dis doi: 10.1055/s-0033-1338113 – volume: 17 start-page: 2309 issue: 12 year: 2011 ident: r27 article-title: Hepatitis E virus antibodies in blood donors, France. publication-title: Emerg Infect Dis doi: 10.3201/eid1712.110371 – volume: 9 start-page: 448 issue: 4 year: 2003 ident: r4 article-title: Hepatitis E virus epidemiology in industrialized countries. publication-title: Emerg Infect Dis doi: 10.3201/eid0904.020351 – volume: 161 start-page: 3 issue: 1 year: 2011 ident: r2 article-title: Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. publication-title: Virus Res doi: 10.1016/j.virusres.2011.02.007 – volume: 60 start-page: 1180 issue: 4 year: 2014 ident: r35 article-title: Decline in hepatitis E virus antibody prevalence in southeastern Germany, 1996-2011. publication-title: Hepatology doi: 10.1002/hep.27244 – volume: 32 start-page: 341 issue: 3 year: 2013 ident: r13 article-title: Chronic hepatitis E infection in lung transplant recipients. publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2012.11.027 – volume: 19 start-page: 778 issue: 7 year: 2004 ident: r14 article-title: Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2004.03437.x – volume: 6 start-page: e21150 issue: 6 year: 2011 ident: r25 article-title: Hepatitis E virus seroprevalence among blood donors in southwest Switzerland. publication-title: PLoS One doi: 10.1371/journal.pone.0021150 – volume: 57 start-page: 1420 issue: 6 year: 2017 ident: r30 article-title: Hepatitis E in Canadian blood donors. publication-title: Transfusion doi: 10.1111/trf.14089 – volume: 54 start-page: 3092 issue: 12 year: 2014 ident: r34 article-title: Past and present of hepatitis E in the Netherlands. publication-title: Transfusion doi: 10.1111/trf.12733 |
| SSID | ssj0043092 |
| Score | 2.4064357 |
| Snippet | Background and aimHepatitis E virus (HEV) is a virus of emerging importance to transfusion medicine. Studies from several European countries, including... Background and aim Hepatitis E virus (HEV) is a virus of emerging importance to transfusion medicine. Studies from several European countries, including... Hepatitis E virus (HEV) is a virus of emerging importance to transfusion medicine. Studies from several European countries, including Switzerland, have... |
| SourceID | pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| SubjectTerms | Blood Blood & organ donations Hepatitis Viruses |
| Title | Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016 |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30180927 https://www.proquest.com/docview/2110459283 https://www.proquest.com/docview/2099888646 https://pubmed.ncbi.nlm.nih.gov/PMC6124188 |
| Volume | 23 |
| WOSCitedRecordID | wos000443855600003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1560-7917 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0043092 issn: 1560-7917 databaseCode: DOA dateStart: 19960101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3di9NAEF96p4gg4rfV81hB8CGkl49NdvMiyFG5F4twFfoWNpuNjdS0NG29_9V_xpndJP1QsAq-hJJsZtPMb3dnJrO_IeQNUz6LpI5cX4bSZb7Azcq55yoYV4FCQrfEFpvgo5GYTJJPvd6Pdi_MZsarStzcJIv_qmo4B8rGrbN_oe5OKJyA36B0OILa4XiU4lvGpanGZOlVWTtDZ1Mu17UD3WPNE-jMDOcSRvZ3eO82ed3J5xUW3jHkrQvMSwcZuVbGDDWbUEyyCJiqsJjHhwF9p14vNxorGKFkDDNkDa-3g-wfC_s9XlfYzpnp2vkmZ5hsVmONiqoGsMHQnG3zGUclklxMJcZQ9jgQtnGivKn7MpL5125tuZqb-rTOR_kFM6Wr7sIYlui1tmW1L22pIr0b8fCFCeF6u5N07CHNJt-dxe2u5QatlgHlcHVA4h8MVLS3D4bXmNsnBkE4CKMBMhXG_m94uQ_Wyy6LEfwnFJmiwBQFpsPrFAWmQZiGUdoIPCG3Ah4lSevvWzOBhZ6p2N09zR3ytnnGiz884b4J9YtfdJjeu2MvjR-Q-42jQ99bgD4kPV09IvdslJjazW-PiW7ASjuw0iE1YKX7YKVlRQ1YqQErtWClAFbagpU2YKUIVopgpas5RbA-IZ8_DMeXV25T-MNVLE5WrhJRloDtyv1Ia8ZVFMsk10WogxjseZHnTKlCq1AXPCs8iaSaLOI8A0fRlx60eUpOq3mlnxOqIk8JJlkGCw34ClwUEnxombFYh0oXUZ-8a99lqhpWfCzOMkuP1G6fiE7AwhLEHH_rWau8tJlA6hQDMixKwOrvk9fdZRiG-CFPVnq-hjbg1gkhYgYinlldd32HhpEv4H3C91DQNUA--f0rVTk1vPLg7MBkLV78-z96Se5uB-wZOV0t1_oVua02gJ_lOTnhE3FuRsFPAC7mYw |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+hepatitis+E+virus+seroprevalence+in+Swiss+blood+donors+and+apparent+decline+from+1997+to+2016&rft.jtitle=Euro+surveillance+%3A+bulletin+europ%C3%A9en+sur+les+maladies+transmissibles&rft.au=Niederhauser%2C+Christoph&rft.au=Widmer%2C+Nadja&rft.au=Hotz%2C+Magdalena&rft.au=Tinguely%2C+Caroline&rft.date=2018-08-30&rft.issn=1560-7917&rft.volume=23&rft.issue=35&rft_id=info:doi/10.2807%2F1560-7917.ES.2018.23.35.1700616&rft.externalDBID=n%2Fa&rft.externalDocID=10_2807_1560_7917_ES_2018_23_35_1700616 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1560-7917&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1560-7917&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1560-7917&client=summon |